Skip to main content

Table 1 Baseline Characteristics of Subjects

From: Development of the ATAQ-IPF: a tool to assess quality of life in IPF

Male, %

82

Ethnicity, %

 

   Caucasian

94

   Black

1

   Other

5

Age yrs

69.3 (7.6)

Smoking status, %

 

   Past

64

   Never

36

Had surgical biopsy, %

56

Time since diagnosis, yrs

2.9 (2.8)

Using supplemental O2, %

 

   Not at all

39

   Exertion and sleep

31

   Continuous

30

FVC%

65 (17)

DLCO%

39 (15)

6MWD, feet

1147 (441)

Taking IPF medications, %

 

   Prednisone

24

   Azathioprine

14

   N-acetyl cysteine

24

Carries a diagnosis of ___, %

 

   Emphysema (by HRCT)

15

   PH by echocardiogram

31

   Stable CAD

24

ATAQ-IPF scores:

Raw T

   Cough

16 (7)

   Dyspnea

19 (6)

   Forethought

14 (6)

   Sleep

16 (5)

   Mortality

17 (5)

   Exhaustion

15 (5)

   Emotional Well-Being

20 (6)

   Social Participation

15 (5)

   Finances

17 (7)

   Independence

14 (5)

   Sexual Health

15 (6)

   Relationships

17 (4)

   Therapies

16 (4)

   Total

210 (46)

  1. Data presented as % or mean (standard deviation); O2 = oxygen; FVC% = percent predicted forced vital capacity; DLCO% = percent predicted diffusing capacity of the lung for carbon monoxide; COPD = chronic obstructive pulmonary disease; HRCT = high-resolution computed tomography scan; PH = pulmonary hypertension; CAD = coronary artery disease
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us